文献速递生殖医学妇科

子宫内膜异位症患者卵母细胞冷冻保存:现状如何?一项系统综述

Oocyte cryopreservation for patients with endometriosis: where are we now? A systematic review.
PubMed 文献 · Reprod Biomed Online · 2025-01-31

该系统综述检索电子数据库后纳入10项观察性研究,因异质性仅作描述性分析。卵母细胞冷冻保存结局方面,随冷冻保存年龄增加及既往子宫内膜异位症手术史,获卵总数一致报告减少;获卵数似乎不取决于子宫内膜异位症类型及卵巢子宫内膜异位囊肿的侧别或大小。卵母细胞成熟率似乎不受子宫内膜异位症手术史影响,但冷冻卵母细胞使用后的随访数据严重缺乏。

要点

  • 随冷冻保存年龄增加及既往子宫内膜异位症手术史,获卵总数一致报告减少。
  • 获卵数似乎不取决于子宫内膜异位症类型及卵巢子宫内膜异位囊肿的侧别或大小。
  • 卵母细胞成熟率似乎不受子宫内膜异位症手术史影响,但冷冻卵母细胞使用后的随访数据严重缺乏。

核心结论

  • 在获得充分随访数据之前,无法以科学确定性确认预防性卵母细胞冷冻保存对所有子宫内膜异位症女性的有效性。

研究设计与样本

  • 系统综述,方案注册于PROSPERO(CRD42023486774),电子数据库检索后纳入10项观察性研究。
  • 因纳入研究异质性,提取数据仅作描述性分析。

主要发现

  • 随冷冻保存年龄增加及既往子宫内膜异位症手术史,获卵总数一致报告减少。
  • 获卵总数似乎不取决于子宫内膜异位症类型及卵巢子宫内膜异位囊肿的侧别或大小。
  • 获卵的减数第二次分裂中期卵母细胞数量趋势与获卵总数基本一致。
  • 卵母细胞成熟率似乎不受子宫内膜异位症手术史影响。
  • 冷冻卵母细胞使用后的随访数据严重缺乏。

局限性

  • 纳入研究存在异质性,提取数据仅作描述性分析。
  • 冷冻卵母细胞使用后的随访数据严重缺乏。
  • 在获得充分随访数据之前,无法以科学确定性确认预防性卵母细胞冷冻保存对所有子宫内膜异位症女性的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The ambiguity of current recommendations on the use of oocyte cryopreservation in patients with endometriosis reflects the lack of comprehensive studies evaluating its efficacy. This review seeks to summarize all available data on the outcomes of oocyte cryopreservation and subsequent IVF, while taking patient characteristics into account. The review protocol was registered in PROSPERO (CRD42023486774). The search of electronic databases identified 10 observational studies. Due to their heterogeneity, the extracted data were only analysed descriptively. In terms of oocyte cryopreservation outcomes, the included studies consistently reported a decrease in the total number of oocytes retrieved as the age at cryopreservation increased and in cases of previous surgery for endometriosis; furthermore, this figure did not seem to depend on the type of endometriosis, and laterality or size of ovarian endometriomas. The trend for the number of metaphase II oocytes retrieved was largely consistent with that of total oocytes retrieved, while the oocyte maturation rate did not appear to be affected by a history of surgery for endometriosis. Conversely, there was a substantial lack of adequate follow-up data on the use of cryopreserved oocytes. Until these data become available, it will not be possible to confirm, with scientific certainty, the effectiveness of preventive oocyte cryopreservation in all women with endometriosis.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Nicolì P, Viganò P, Saccone G, et al. Oocyte cryopreservation for patients with endometriosis: where are we now? A systematic review. Reprod Biomed Online. 2025. PMID: 40446646. doi:10.1016/j.rbmo.2025.104839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。